Add Company
Join Now

Indi Molecular Revenue and Competitors

License our Company Data API

Location

N/A

Total Funding

Biotech

Industry

Estimated Revenue & Valuation

  • Indi Molecular's estimated annual revenue is currently $620k per year.(i)
  • Indi Molecular's estimated revenue per employee is $155,000

Employee Data

  • Indi Molecular has 4 Employees.(i)
  • Indi Molecular grew their employee count by -20% last year.

Indi Molecular's People

NameTitleEmail/Phone
1
vp R/D OperationsReveal Email/Phone
2
VP Intellectual PropertyReveal Email/Phone
3
President Strategy & Technical Business DevelopmentReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$4.4M57-8%$53MN/A
#2
$21.2M137-26%$110MN/A
#3
$0.9M60%N/AN/A
#4
$2.3M1515%N/AN/A
#5
$1.6M10-17%N/AN/A
#6
$0.7M950%N/AN/A
#7
$11.5M74-12%N/AN/A
#8
$0.4M27510%$236.7MN/A
#9
$4M51-74%$160MN/A
#10
$2.3M1515%N/AN/A
Add Company

What Is Indi Molecular?

Indi Molecular is developing protein catalyzed capture (PCC) agents as a small synthetic molecule replacement for antibody-based therapeutics. PCCs are poised to play a central role in therapy given their ability to be deployed as both a precision in vivo PET diagnostic and as a targeted therapeutic. For radiotherapy this dual role is accomplished by choice of the complexed radionuclide sharing the same chelation chemistry. Chemotherapy can similarly be specifically delivered to diseased cells by the protein catalyzed capture technology. The company launched in 2013 with a $1.8 million seed round, followed by an $11.5 million Series A in 2017.

keywords:N/A

N/A

Total Funding

4

Number of Employees

$620k

Revenue (est)

-20%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$0.3M4-20%N/A
#2
$0.3M4N/AN/A
#3
$0.3M433%N/A
#4
$0.3M40%N/A
#5
$0.1M4-20%N/A